16.12 Medical Technologies Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Investors
-
4
16.12 Medical Technologies General Information
Description
Developer of the blood clot finder device designed to monitor and predict a thrombotic event, the cause of stroke, and heart attack in a short period. The company's devices are used to measure platelet activation and fibrin formation in a blood sample, enabling healthcare providers to evaluate the disorder and to monitor the effects of antiplatelet and anticoagulation therapy.
Contact Information
Website
www.1612medical.comCorporate Office
- Via Roveredo 20-B
- 33170 Pordenone
- Italy
Corporate Office
- Via Roveredo 20-B
- 33170 Pordenone
- Italy
16.12 Medical Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | Completed | Generating Revenue | ||||
| 3. Grant | 30-Nov-2018 | Completed | Generating Revenue | |||
| 2. Grant | 20-Jun-2018 | $58.4K | $1.23M | Completed | Generating Revenue | |
| 1. Angel (individual) | 08-May-2012 | $1.23M | $1.23M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
16.12 Medical Technologies Patents
16.12 Medical Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4016076-A1 | Apparatus for the evaluation of blood parameters | Inactive | 21-Dec-2020 | ||
| EP-4264259-A1 | Method for analyzing individual cells or particulates in blood using fluorescence | Pending | 21-Dec-2020 | ||
| WO-2022136961-A1 | Method for analyzing individual cells or particulates in blood using fluorescence | Inactive | 21-Dec-2020 | ||
| CA-3203051-A1 | Method for evaluating blood parameters | Pending | 21-Dec-2020 | ||
| EP-4264282-A1 | Method for evaluating blood parameters | Active | 21-Dec-2020 | G01N33/86 |
16.12 Medical Technologies Signals
16.12 Medical Technologies Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Union | Government | |||
| Horizon 2020 | Government | |||
| Italian Angels for Growth | Angel Group | Minority | ||
| MGH7 Venture Capital | Venture Capital | Minority |
16.12 Medical Technologies FAQs
-
When was 16.12 Medical Technologies founded?
16.12 Medical Technologies was founded in 2005.
-
Where is 16.12 Medical Technologies headquartered?
16.12 Medical Technologies is headquartered in Pordenone, Italy.
-
What is the size of 16.12 Medical Technologies?
16.12 Medical Technologies has 6 total employees.
-
What industry is 16.12 Medical Technologies in?
16.12 Medical Technologies’s primary industry is Diagnostic Equipment.
-
Is 16.12 Medical Technologies a private or public company?
16.12 Medical Technologies is a Private company.
-
What is 16.12 Medical Technologies’s current revenue?
The current revenue for 16.12 Medical Technologies is .
-
How much funding has 16.12 Medical Technologies raised over time?
16.12 Medical Technologies has raised $1.23M.
-
Who are 16.12 Medical Technologies’s investors?
European Union, Horizon 2020, Italian Angels for Growth, and MGH7 Venture Capital have invested in 16.12 Medical Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process